Eversana Intouch

JANUARY 20, 2022

The following content was originally published by EVERSANA last June; read on to learn more, and then get EVERSANA’s complete white paper about the benefits of creating reusable infrastructure and resources when it comes to product launches.

Pharma 52

Pharma Pharmaceutical products Consulting Management 52

Pharmaceutical Technology

SEPTEMBER 16, 2022

A 2021 GlobalData poll among readers of Pharmaceutical Technology , found that 43% of respondents agreed environmental issues were the most important aspect of ESG that pharma companies needed to address. Download the white paper to learn more. [1] Industry awareness of the issues. The road from ambition to action.

Pharmaceutical 52

Pharmaceutical Transportation Electronics Pharma 52

Pharmaceutical Technology

JANUARY 20, 2023

Pharmaceutical companies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. Consumers are taking notice of these metrics, and there is demand for action from pharma.

Pharma 142

Pharma Pharmaceutical Manufacturing Distribution 142

Pharmaceutical Technology

JANUARY 16, 2023

Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets.

Pharma 64

Pharma Pharmaceutical Manufacturing Marketing 64

Pharmaceutical Technology

FEBRUARY 15, 2023

Big data analysis can be enormously powerful in providing insights for business strategy throughout the pharma value chain, including in the acceleration of drug discovery and development, optimization of manufacturing processes, management of supply chains and the creation of innovative sales and marketing strategies.

Pharma 52

Pharma Pharmaceutical Manufacturing Medicine 52

Pharmaceutical Technology

JANUARY 16, 2023

Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets.

Pharma 52

Pharma Pharmaceutical Manufacturing Marketing 52

Pharmaceutical Technology

NOVEMBER 30, 2022

A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating packaging systems to determine their ability to protect the stability and sterility of pharmaceutical products. Pharma 4.0. In the fast-approaching era of Pharma 4.0,

Food and Drug Administration 52

Food and Drug Administration Pharmaceutical products Manufacturing Pharmaceutical 52